You are here


Recent Headlines

Nearly 600 U.S. clinics could be selling unregulated stem cell treatments

The risks of “stem cell tourism” might be overplayed, according to a new paper published June 30 in the journal Cell Stem Cell. But only because the real risks of unregulated stem cells might actually be within the U.S.

Biden rallies participants to double cancer progress in 'moonshot' kick-off

Vice President Joe Biden led a major step toward completing his “moonshot” task of curing cancer June 29, when he spoke at the first Cancer Moonshot Summit.

FDA approves test for quicker detection of hospital ‘superbugs’

The Food and Drug Administration (FDA) has given a thumbs up to a test hospitals can use to identify certain types of antibiotic-resistant infections more quickly.

Study reveals differing standards for approval of American, European medical devices

Medical devices play a vital role in patient care, but how they are approved and regulated are vastly different in the United States compared to the European Union.

Health IT groups want more time to prepare for MACRA

Electronic health record (EHR) vendors and the clinicians they serve need more than a few months to adapt to the Medicare Access and CHIP Reauthorization Act, according to numerous comments submitted to CMS by health IT groups.

Patients unhappy with UnitedHealth’s limits on insulin pumps

A new deal between UnitedHealthcare and device maker Medtronic means fewer options for UnitedHealth customers who need insulin pumps to treat Type 1 diabetes.

CDC failed to disclose lab mishaps to Congress

The Centers for Disease Control and Prevention (CDC) told Congress it left out 34 incident reports involving lab mistakes from information it provided to a congressional investigation in 2014, according to USA Today.

IT group wants interoperability standards for drug monitoring

As the House and Senate work in a conference committee on anti-opioid abuse legislation, a coalition called Health IT Now has asked lawmakers to lay out more specific standards on how different states’ prescription drug monitoring programs (PDMPs) will be interoperable.


Study claims high drug prices lead to more long-term savings

A study released by Frank R. Lichtenberg of the Montreal Economic Institute said while the price of prescription drugs remains high, the implementation of medical innovation leads to more savings in the long run.

Zika vaccine goes to trial, but governmental and medical challenges abound

The effort to contain the Zika virus in North America could see a much-needed boost in the near future. Human-based vaccine trials could start within weeks, the drug’s developer announced.